Supernus Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Good morning. My name is Jackson Lowrie, and I'm a member of the JPMorgan health care investment banking coverage team. It's my pleasure to introduce you to Jack Khattar, the CEO of Supernus Pharmaceuticals.
And just as we do finish, there will be a breakout in Elizabethan C, which is just next door. So I'll pass over to Jack.
Thank you, and good morning. Before I get started, just try to remind everyone about the forward-looking statements I will be making during this session and the Q&A session. So please check the SEC filings for all the risk factors associated with the business.
Very quickly, for those of you who may not be very familiar with us, Supernus Pharmaceuticals actually has been around for more than 25 years. We operated for many years as a division of Shire Pharmaceuticals, so from 1997 until 2005, and then we spun out of Shire at the end of '05
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
